Differentiation-Dependent Doxorubicin Toxicity on H9c2 Cardiomyoblasts
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differentiation-Dependent Doxorubicin Toxicity on H9c2 Cardiomyoblasts
Authors
Keywords
-
Journal
Cardiovascular Toxicology
Volume 12, Issue 4, Pages 326-340
Publisher
Springer Nature
Online
2012-06-29
DOI
10.1007/s12012-012-9177-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endogenous Bmp4 in myoblasts is required for myotube formation in C2C12 cells
- (2011) Takenao Umemoto et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Effect of hypothermia on doxorubicin-induced cardiac myoblast signaling and cell death
- (2011) Thomas J. L'Ecuyer et al. CARDIOVASCULAR PATHOLOGY
- Metabolic Remodeling During H9c2 Myoblast Differentiation: Relevance for In Vitro Toxicity Studies
- (2011) Sandro L. Pereira et al. Cardiovascular Toxicology
- Isoproterenol Cytotoxicity is Dependent on the Differentiation State of the Cardiomyoblast H9c2 Cell Line
- (2011) Ana F. Branco et al. Cardiovascular Toxicology
- Traveling Bax and Forth from Mitochondria to Control Apoptosis
- (2011) Maria Eugenia Soriano et al. CELL
- The Adenine Nucleotide Translocase 2, a Mitochondrial Target for Anticancer Biotherapy
- (2011) Ossama Sharaf el dein et al. CURRENT DRUG TARGETS
- Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol
- (2011) Goncalo C. Pereira et al. CURRENT PHARMACEUTICAL DESIGN
- The Permeability Transition Pore Controls Cardiac Mitochondrial Maturation and Myocyte Differentiation
- (2011) Jennifer R. Hom et al. DEVELOPMENTAL CELL
- Ischemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2
- (2011) Hong-Lin Zhu et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Bcl-xLregulates mitochondrial energetics by stabilizing the inner membrane potential
- (2011) Ying-bei Chen et al. JOURNAL OF CELL BIOLOGY
- Modulation of the mitochondrial permeability transition by cyclophilin D: Moving closer to F0–F1 ATP synthase?
- (2011) Christos Chinopoulos et al. MITOCHONDRION
- Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47phox
- (2011) Jessica A. Sipkens et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor
- (2011) Xi-Yong Yu et al. PLoS One
- p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury
- (2011) Joyce M. Velez et al. PLoS One
- Cardiomyocyte Specific Ablation of p53 Is Not Sufficient to Block Doxorubicin Induced Cardiac Fibrosis and Associated Cytoskeletal Changes
- (2011) Tiam Feridooni et al. PLoS One
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
- (2011) J Huelsenbeck et al. Cell Death & Disease
- Cardiac Function in 5-Year Survivors of Childhood Cancer
- (2010) Helena J. van der Pal et al. ARCHIVES OF INTERNAL MEDICINE
- Dimethylaminopyridine derivatives of lupane triterpenoids are potent disruptors of mitochondrial structure and function
- (2010) Jon Holy et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Nitrogen Compounds Prevent H9c2 Myoblast Oxidative Stress-Induced Mitochondrial Dysfunction and Cell Death
- (2010) João P. Silva et al. Cardiovascular Toxicology
- Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice
- (2010) Chengqun Huang et al. CIRCULATION
- Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model
- (2010) K. Van Calsteren et al. GYNECOLOGIC ONCOLOGY
- Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic?
- (2010) Joy M. Fulbright et al. Current Oncology Reports
- Overexpression of ornithine decarboxylase increases myogenic potential of H9c2 rat myoblasts
- (2009) Marco Govoni et al. AMINO ACIDS
- Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
- (2009) Vilma A. Sardão et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway
- (2009) Narasimman Gurusamy et al. CARDIOVASCULAR RESEARCH
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
- (2009) Antonella De Angelis et al. CIRCULATION
- Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation
- (2009) Elisa Bregant et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Anthracyclines for gestational breast cancer: course and outcome of pregnancy
- (2008) H. A. Azim et al. ANNALS OF ONCOLOGY
- Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets
- (2008) Vilma A. Sardão et al. CELL BIOLOGY AND TOXICOLOGY
- Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes
- (2008) Eugene A. Konorev et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation